No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
---|---|---|---|---|---|---|---|---|
1 | 04260160470587 | delta System (US/CA) | 201001 | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. | GGN,JPA | Plasma, Coagulation Control,System, Multipurpose For In Vitro Coagulation Studies | 2 | ROTEM® |
2 | 04260160470372 | sigma | 211000 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | JPA | System, Multipurpose For In Vitro Coagulation Studies | 2 | ROTEM® |
3 | 04260160470358 | sigma ROTROL P | 555202 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | JPA | System, Multipurpose For In Vitro Coagulation Studies | 2 | ROTEM® |
4 | 04260160470341 | sigma ROTROL N | 555201 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | JPA | System, Multipurpose For In Vitro Coagulation Studies | 2 | ROTEM® |
5 | 04260160470327 | sigma complete + hep | 555502 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | JPA | System, Multipurpose For In Vitro Coagulation Studies | 2 | ROTEM® |
6 | 04260160470242 | ex-tem® | 503-05-US | The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the extrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). | JPA | System, Multipurpose For In Vitro Coagulation Studies | ROTEM® | |
7 | 04260160470112 | ROTROL P | 503-25-US, 503-25 | ROTROL P is a quality control material for monitoring accuracy and precision of ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. | GGN,JPA | Plasma, Coagulation Control,System, Multipurpose For In Vitro Coagulation Studies | ROTEM® | |
8 | 04260160470105 | ROTROL N | 503-24-US, 503-24 | ROTROL N is a quality control material for monitoring accuracy and precision of ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. | JPA,GGN | System, Multipurpose For In Vitro Coagulation Studies,Plasma, Coagulation Control | ROTEM® | |
9 | 04260160470099 | star-tem® 20 | 503-10-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp. | GGN,JPA | Plasma, Coagulation Control,System, Multipurpose For In Vitro Coagulation Studies | ROTEM® | |
10 | 04260160470082 | hep-tem® | 503-09-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). | JPA,GGN | System, Multipurpose For In Vitro Coagulation Studies,Plasma, Coagulation Control | ROTEM® | |
11 | 04260160470075 | fib-tem® | 503-06-US | The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking platelet contribution to the clot firmness. fib-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameter Clot Firmness (A20/MCF). | JPA | System, Multipurpose For In Vitro Coagulation Studies | ROTEM® | |
12 | 04260160470068 | ap-tem® | 503-04-US | The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® d The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking hyperfibrinolysis by aprotinin. ap-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). | JPA | System, Multipurpose For In Vitro Coagulation Studies | ROTEM® | |
13 | 04260160470020 | delta System | 200100-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. | JPA,GGN | System, Multipurpose For In Vitro Coagulation Studies,Plasma, Coagulation Control | 2 | ROTEM® |
No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
---|---|---|---|---|---|---|
1 | 15391521421125 | DSF | Destiny System Fluid | TCOAG IRELAND LIMITED | ||
2 | 15391521420708 | T5102 | TriniCAL™ Reference Plasma | TCOAG IRELAND LIMITED | ||
3 | 13607450011392 | 01139 | Pool Norm | DIAGNOSTICA STAGO | ||
4 | 10885074184828 | 550-01 | CONTROL 550-01 CLOTTRAC CWB 11L 15BX | CLOTtrac® | MEDTRONIC, INC. | |
5 | 10859394006184 | 35-201 | 35-201 | Assayed Reference Plasma L-2 10 x 1 ml | PlasmaRef ARL-2 | R 2 DIAGNOSTICS, INC. |
6 | 10859394006177 | 33-201 | 33-201 | Assayed Reference Plasma 10 x 1 ml | PlasmaRef ARN | R 2 DIAGNOSTICS, INC. |
7 | 10812747018463 | 07-605-US | Citrated: K, RT, FF | Hemostasis System | HAEMONETICS CORPORATION | |
8 | 10812747018456 | 01-197 | ELECTRONIC PIPPETTE KIT, 1000UL | TEG5000 | HAEMONETICS CORPORATION | |
9 | 10812747018210 | 07-045 | VALIDATION KIT, TEG5000 | TEG5000 | HAEMONETICS CORPORATION | |
10 | 10812747018203 | 07-044 | STARTER KIT, TEG5000 | TEG5000 | HAEMONETICS CORPORATION | |
11 | 10812747018159 | 01-097 | PIPETTE KIT, 1000UL | TEG5000 | HAEMONETICS CORPORATION | |
12 | 10812747018142 | 01-096 | PIPETTE KIT, 100UL | TEG5000 | HAEMONETICS CORPORATION | |
13 | 10812747018043 | 07-012 | CALCIUM CHLORIDE, 0.2M, 5 ML | TEG HEMOSTASIS SYSTEM | HAEMONETICS CORPORATION | |
14 | 10711234540121 | 000GCCM | 000GCCM | Centralized Configuration Manager Software | Centralized Configuration Manager Software | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
15 | 10711234540114 | HR1003 | HR1003 | Temperature Verification Tube | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
16 | 10711234540107 | J-1001 | J-1001 | Temperature Verification Cartridge | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
17 | 10711234540091 | JEA-QC | JEA-QC | Electronic System Verification - Abnormal | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
18 | 10711234540084 | JEN-QC | JEN-QC | Electronic System Verification - Normal | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
19 | 10711234540077 | HE-J04 | HE-J04 | Electronic System Verification Kit | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
20 | 10711234540060 | HR1003 | HR1003 | Temperature Verification Tube | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
21 | 10711234540053 | HE-ESV | HE-ESV | Electronic System Verification Tube | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
22 | 10711234540046 | DCJ-005 | DCJ-005 | Protective Sleeves | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
23 | 10711234540039 | RPM-CD | RPM-CD | Report Maker V6.01 | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
24 | 10711234540022 | HRDM3CD | HRDM3CD | Data Manager V3.0 | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
25 | 10711234520062 | HRS.110-D | HRS.110-D | Hemochron Whole Blood Coagulation System - Hemochron Response Instrument (Demonstration) | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
26 | 10711234520055 | HRS.110-L | HRS.110-L | Hemochron Whole Blood Coagulation System - Hemochron Response Instrument (Loaner) | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
27 | 10711234520048 | HRS.RF | HRS.RF | Hemochron Whole Blood Coagulation System - Hemochron Response Instrument Refurbished | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
28 | 10711234520017 | HRS.110 | HRS.110 | Hemochron Whole Blood Coagulation System - Hemochron Response Instrument | Hemochron Whole Blood Coagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
29 | 10711234515044 | 000GH100L | 000GH100L | GEM Hemochron 100 System (Loaner) | GEM Hemochron 100 System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
30 | 10711234515006 | 000GH100 | 000GH100 | GEM Hemochron 100 System - GEM Hemochron 100 Instrument | GEM Hemochron 100 System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
31 | 10711234510070 | ELITEL | ELITEL | Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instru Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instrument (Loaner) | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
32 | 10711234510056 | ELITEDEMO | ELITEDEMO | Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instru Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instrument (Demonstration) | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
33 | 10711234510025 | ELITERF | ELITERF | Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instru Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instrument Refurbished | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
34 | 10711234510018 | ELITE | ELITE | Hemochron Whole Blood Microcoagulation System - Hemochron Signature Elite Instrument | Hemochron Whole Blood Microcoagulation System | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
35 | 10711234170373 | 000DCGLR-2 | 000DCGLR-2 | directCHECK GH100 ACTLR2 15/box | directCHECK ACT-LR Whole Blood Control, Level 2 | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
36 | 10711234170366 | 000DCGLR-1 | 000DCGLR-1 | directCHECK GH100 ACTLRL1 15/box. | directCHECK ACT-LR Whole Blood Controls, Level 1 | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
37 | 10711234170359 | 000DCGACT-2 | 000DCGACT-2 | directCHECK GH100 ACT+L2 15/box | directCHECK ACT+ Whole Blood Control, Level 2 | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
38 | 10711234170342 | 000DCGACT-1 | 000DCGACT-1 | directCHECK GH100 ACT+L1 15/box | directCHECK ACT+ Whole Blood Control Level 1 | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
39 | 10711234170243 | DCJLR-N | DCJLR-N | directCHECK ACT-LR - Normal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
40 | 10711234170236 | DCJPT-N | DCJPT-N | directCHECK PT - Normal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
41 | 10711234170229 | DCJACT-N | DCJACT-N | directCHECK ACT+ Normal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
42 | 10711234170175 | DCJCAPTT-A | DCJCAPTT-A | directCHECK Citrate APTT - Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
43 | 10711234107102 | DCP214-A | DCP214-A | HepCheck P214 - Abnormal 15/box | HepCheck Whole Blood Control | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
44 | 10711234107096 | DCP214-N | DCP214-N | HepCheck P214 - Normal 15/box | HepCheck Whole Blood Control | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
45 | 10711234107089 | DCJLR-A | DCJLR-A | directCHECK ACT-LR Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
46 | 10711234107072 | DCJCPT-N | DCJCPT-N | directCHECK Citrate PT - Normal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
47 | 10711234107065 | DCJCPT-A | DCJCPT-A | directCHECK Citrate PT - Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
48 | 10711234107058 | DCJACT-A | DCJACT-A | directCHECK ACT+ Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
49 | 10711234107041 | DCJPT-A | DCJPT-A | directCHECK PT - Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |
50 | 10711234107034 | DCJAPTT-A | DCJAPTT-A | directCHECK APTT - Abnormal 15/box | directCHECK Whole Blood Controls | ACCRIVA DIAGNOSTICS HOLDINGS, INC. |